BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15345009)

  • 1. RE: How safe is Australian radiotherapy?
    Lynch R; Francis M; Bulmer M
    Australas Radiol; 2004 Sep; 48(3):438-40. PubMed ID: 15345009
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Editorial: How safe is safe? Risk in radiotherapy.
    Morgan G
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1602; author reply 1602. PubMed ID: 21414521
    [No Abstract]   [Full Text] [Related]  

  • 3. French hospital and its staff are charged over radiotherapy errors.
    Benkimoun P
    BMJ; 2012 Oct; 345():e6802. PubMed ID: 23065310
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging in the radiotherapy treatment room.
    Kron T
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):99-100. PubMed ID: 18373798
    [No Abstract]   [Full Text] [Related]  

  • 5. The Australian Clinical Dosimetry Service: a commentary on the first 18 months.
    Williams I; Kenny J; Lye J; Lehmann J; Dunn L; Kron T
    Australas Phys Eng Sci Med; 2012 Dec; 35(4):407-11. PubMed ID: 23055126
    [No Abstract]   [Full Text] [Related]  

  • 6. Tools for developing a quality management program: proactive tools (process mapping, value stream mapping, fault tree analysis, and failure mode and effects analysis).
    Rath F
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S187-90. PubMed ID: 18406925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Glasgow incident--a physicist's reflections.
    Mayles WP
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):4-7. PubMed ID: 17305250
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Deye J; Purdy J; Vikram B
    J Natl Cancer Inst; 2008 Sep; 100(17):1263-4; author reply 1265-7. PubMed ID: 18728288
    [No Abstract]   [Full Text] [Related]  

  • 9. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy.
    Potters L; Steinberg M; Rose C; Timmerman R; Ryu S; Hevezi JM; Welsh J; Mehta M; Larson DA; Janjan NA; ;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1026-32. PubMed ID: 15519771
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation therapy treatment verification imaging in Australia and New Zealand.
    Rybovic M; Banati RB; Cox J
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):183-90. PubMed ID: 18373812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Multicentre quality assurance of intensity-modulated radiation therapy planning: beware the benchmarker.
    Williams MJ; Bailey MJ; Forstner D; Metcalfe PE
    J Med Imaging Radiat Oncol; 2008 Jun; 52(3):303. PubMed ID: 18477127
    [No Abstract]   [Full Text] [Related]  

  • 12. Critique of traditional quality assurance paradigm.
    Thomadsen B
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S166-9. PubMed ID: 18406919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statistical Process Control (SPC) can help prevent treatment errors without increasing costs in radiotherapy].
    Govindarajan R; Llueguera E; Melero A; Molero J; Soler N; Rueda C; Paradinas C
    Rev Calid Asist; 2010; 25(5):281-90. PubMed ID: 20675168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.
    Tai KH; Duchesne G; Turner S; Kneebone A; See A; Gogna K; Berry M
    Australas Radiol; 2004 Dec; 48(4):502-8. PubMed ID: 15601331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery.
    Morganti AG; Deodato F; Zizzari S; Cilla S; Digesu' C; Macchia G; Panunzi S; De Gaetano A; Piermattei A; Cellini N; Valentini V
    Radiother Oncol; 2008 Dec; 89(3):320-9. PubMed ID: 18701176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre quality assurance of intensity-modulated radiotherapy planning: beware the benchmarker.
    Back M; Oliver L; Bromley R; Eade T
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):197. PubMed ID: 18373816
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiotherapy in the management of clinically localized prostate cancer: evolving standards, consensus, controversies and new directions.
    Speight JL; Roach M
    J Clin Oncol; 2005 Nov; 23(32):8176-85. PubMed ID: 16278470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A virtual reality solution for evaluation of radiotherapy plans.
    Patel D; Muren LP; Mehus A; Kvinnsland Y; Ulvang DM; Villanger KP
    Radiother Oncol; 2007 Feb; 82(2):218-21. PubMed ID: 17224194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials.
    Williams MJ; Bailey M; Forstner D; Metcalfe PE
    Australas Radiol; 2007 Oct; 51(5):472-9. PubMed ID: 17803801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments.
    Fu W; Yang Y; Li X; Heron DE; Huq MS; Yue NJ
    Phys Med Biol; 2006 Oct; 51(20):5321-31. PubMed ID: 17019041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.